Bristol Myers (BMY) Gets FDA Nod for Breyanzi’s Label Expansion
ZacksBristol Myers (BMY) obtains FDA approval for the label expansion of CAR T cell therapy, Breyanzi, for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).